Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 April 2004

Severe preeclampsia and eclampsia in Kerman, Iran: complications and outcomes

Bibi Shahnaz Aali, Jila Ghafoorian, Sakineh Mohamad-Alizadeh

Med Sci Monit 2004; 10(4): CR163-167 :: ID: 11630

Abstract

Background:Our objective was to assess the frequency, epidemiological factors, complications, and outcome of severe preeclampsia and eclampsia and compare them according to severity of the condition in Kerman, southeastern Iran.Material/Methods: A prospective study was performed on 200 consecutive cases of severe preeclampsia and eclampsia referred to the Kerman University Maternity Center from June 2001 to December 2002. Demographic data and complications were described and severe preeclampsia and eclampsia compared using t-student’s and chi2 tests.Results: Severe preeclampsia occurred in 3% and eclampsia in 0.6% of deliveries during the period of study. The majority of patients were young and primigravida, especially in the eclampsia group. 72.7% of eclamptic patients suffered their first convulsion at home and not in the presence of medical help. HELLP syndrome, disseminated intravascular coagulation, acute renal failure, neurological complications, and acute respiratory distress syndrome were the main maternal complications, all occurring more frequently in eclamptic patients. The frequency of pulmonary edema, placental abruption, postpartum hemorrhage, and aspiration pneumonia was not significantly different between the two groups. More than half of patients underwent cesarean delivery. Early neonatal mortality rate was 13% in the entire cohort. All six maternal deaths during the period of the study occurred in eclamptic cases (mortality rate 18%), four relating to patients who had not received prenatal care.Conclusions: Severe preeclampsia carries a high risk of maternal and neonatal morbidities and mortality in Kerman. This risk increases in the presence of eclampsia, particularly in neglected cases who have not sought prenatal care.

Keywords: Cesarean Section, Eclampsia - complications, HELLP Syndrome - etiology, Infant Mortality, Infant, Newborn, Iran, Pre-Eclampsia - complications, Pregnancy, Cesarean Section, Eclampsia - complications, HELLP Syndrome - etiology, Infant Mortality, Infant, Newborn, Iran, Pre-Eclampsia - complications, Pregnancy

Add Comment 0 Comments

Editorial

01 March 2025 : Editorial  

Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials

Dinah V. Parums

DOI: 10.12659/MSM.948672

Med Sci Monit 2025; 31:e948672

0:00

In Press

Clinical Research  

Comparative Analysis of Laser Therapies for Striae Distensae: Fractional CO₂ vs Combined Q-Switch Nd:YAG

Med Sci Monit In Press; DOI: 10.12659/MSM.947464  

Database Analysis  

Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter Access

Med Sci Monit In Press; DOI: 10.12659/MSM.947298  

Clinical Research  

Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac Surgery

Med Sci Monit In Press; DOI: 10.12659/MSM.947462  

Clinical Research  

Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.945964  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,110,480

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,343

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   27,671

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   21,887

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750